「japan」の検索結果
85件：71～75件目を表示
-
of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distributi...
https://www.senju.co.jp/system/files/content_news/2023-11/ENG__20231101.pdf -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
) PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeApplication under review（Japan） SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlusion (CRAO)P3（Japan） SJP-0170Gla...
http://www.senju.co.jp/english/rd/pipeline.html -
Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
Ltd. Mochida Pharmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
Ltd. Mochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf